What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Alberto Chiarugi mostly deals with Poly ADP ribose polymerase, Pharmacology, Biochemistry, Cell biology and Programmed cell death.
The various areas that Alberto Chiarugi examines in his Poly ADP ribose polymerase study include Apoptosis, DNA repair and NAD+ kinase.
His NAD+ kinase research includes themes of Glycolysis, Molecular biology, Flow cytometry, Membrane potential and Mitochondrion.
Alberto Chiarugi has included themes like Nitric oxide synthase, Meninges, Kynurenine and Olaparib in his Pharmacology study.
His work deals with themes such as Transcription factor, Neurodegeneration and Neuroscience, Neuron, which intersect with Cell biology.
He combines subjects such as Cytochrome, Cell nucleus and Ischemia with his study of Programmed cell death.
His most cited work include:
- The NAD metabolome — a key determinant of cancer cell biology (331 citations)
- Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited (258 citations)
- Delayed inflammation in rat meninges: implications for migraine pathophysiology. (245 citations)
What are the main themes of his work throughout his whole career to date?
Alberto Chiarugi mainly focuses on Poly ADP ribose polymerase, Pharmacology, Neuroprotection, Biochemistry and Molecular biology.
His Poly ADP ribose polymerase research is multidisciplinary, incorporating perspectives in Programmed cell death, NAD+ kinase and Cell biology.
His Cell biology study incorporates themes from Apoptosis, Transcription factor, Transcriptional regulation and Neuroscience.
His work investigates the relationship between Pharmacology and topics such as Kynurenine that intersect with problems in Indoleamine 2,3-dioxygenase and Enzyme inhibitor.
His Neuroprotection research integrates issues from Neurodegeneration, Hippocampal formation, Brain ischemia, Ischemia and Brain damage.
As part of the same scientific family, Alberto Chiarugi usually focuses on Molecular biology, concentrating on Protein kinase B and intersecting with Neuron.
He most often published in these fields:
- Poly ADP ribose polymerase (27.46%)
- Pharmacology (23.24%)
- Neuroprotection (19.72%)
What were the highlights of his more recent work (between 2018-2021)?
- Pharmacology (23.24%)
- Migraine (4.93%)
- Dexpramipexole (4.23%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Pharmacology, Migraine, Dexpramipexole, NOD mice and Experimental autoimmune encephalomyelitis.
In general Pharmacology study, his work on Neuropathic pain often relates to the realm of Chloramphenicol, thereby connecting several areas of interest.
His NOD mice research includes elements of Myelin oligodendrocyte glycoprotein, Lymphocyte proliferation, Immunology and Entinostat.
Alberto Chiarugi works mostly in the field of Immunology, limiting it down to topics relating to Myelin and, in certain cases, Dexamethasone, Neurodegeneration and Immune system.
Alberto Chiarugi has researched Experimental autoimmune encephalomyelitis in several fields, including Cancer research, Panobinostat and Givinostat.
His Neuroprotection research is multidisciplinary, incorporating elements of Hippocampal formation, Mitochondrion and Pathogenesis.
Between 2018 and 2021, his most popular works were:
- Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models. (9 citations)
- Ultra-rapid brain uptake of subcutaneous sumatriptan in the rat: Implication for cluster headache treatment: (6 citations)
- Enhanced dissolution, permeation and oral bioavailability of aripiprazole mixed micelles: In vitro and in vivo evaluation. (5 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
Alberto Chiarugi focuses on Pharmacology, Pharmacokinetics, Neuropathic pain, Nociception and Tolerability.
His research in Pharmacology intersects with topics in Sumatriptan, Disease cluster, Symptomatic treatment, Brain uptake and Migraine.
His Pharmacokinetics study combines topics in areas such as Chromatography, Polyethylene glycol, Bioavailability and In vivo.
His Neuropathic pain research integrates issues from Nociceptor and Dorsal root ganglion.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
